Technology News and Research

RSS

Oncologists underestimate patient use of complementary medicine after breast cancer diagnosis

Nearly three-quarters of breast cancer patients (73%) report using at least one type of complementary medicine after cancer diagnosis, while oncologists believe that less than half (43%) of patients are using these approaches during cancer care.

3 Jun 2021

Study: Some Type 2 diabetes patients can benefit from bone marrow stem cell transplants

Type 2 diabetes patients who are not overweight and who have had the disorder for less than a decade can benefit from stromal stem cells transplanted from their own bone marrow, according to a study published today in STEM CELLS Translational Medicine.

3 Jun 2021

How can nanomaterials help in the fight against COVID-19?

Researchers have reviewed different types of nanomaterials and how they can be used for the detection, prevention, and treatment of coronavirus disease 2019 (COVID-19).

3 Jun 2021

Researchers develop rapid antibody screening method for novel COVID-19 therapeutics development

New research undertaken by researchers in the USA describes two parallel but distinct in vivo approaches for the accelerated discovery of antibodies targeting SARS-CoV-2 spike protein.

3 Jun 2021

Scientists assess the filtration efficacy of 227 models of face masks sold in Brazil

The novel coronavirus is transmitted mainly via inhalation of saliva droplets or respiratory secretions suspended in air, so that face covering and social distancing are the most effective ways to prevent COVID-19 until enough vaccines are available for all.

3 Jun 2021

New nano-sized particles help improve detection of tumors within the body

Nano-sized particles have been engineered in a new way to improve detection of tumors within the body and in biopsy tissue, a research team in Sweden reports. The advance could enable identifying early stage tumors with lower doses of radiation.

3 Jun 2021

Centivax and US Naval Medical Research Center to begin Phase I clinical trial of antibody therapeutics

Centivax Inc. announced today that it has entered into a strategic partnership with the U.S. Naval Medical Research Center (NMRC) for Phase I clinical development of Centi-B9, Centivax's SARS-CoV-2 broad-spectrum injectable antibody therapeutic and prophylactic.

3 Jun 2021

E6-specific inhibitors offer a unique, strategic approach for treating HPV-HNSCC

Oncotarget published "A high-content AlphaScreen™ identifies E6-specific small molecule inhibitors as potential therapeutics for HPV+ head and neck squamous cell carcinomas" which reported that the incidence of human papillomavirus-positive head and neck squamous cell carcinoma has increased dramatically over the past decades due to an increase in infection of the oral mucosa by HPV.

3 Jun 2021

Study could help scientists, policymakers communicate about zoonotic diseases

A new study from North Carolina State University found that certain types of messages could influence how people perceive information about the spread of diseases from wildlife to humans.

3 Jun 2021

New process could reinvigorate the search for natural product drugs to treat cancers, viral infections

Researchers from Carnegie Mellon University's Computational Biology Department in the School of Computer Science have developed a new process that could reinvigorate the search for natural product drugs to treat cancers, viral infections and other ailments.

3 Jun 2021

NCI grants more than $4.2 million to launch Cancer Epitope Database and Analysis Resource

Researchers are about to welcome a new one-stop shop for crucial information on how the immune system targets cancers.

3 Jun 2021

Scientists develop new gene drive with a built-in genetic barrier

CRISPR-based technologies offer enormous potential to benefit human health and safety, from disease eradication to fortified food supplies. As one example, CRISPR-based gene drives, which are engineered to spread specific traits through targeted populations, are being developed to stop the transmission of devastating diseases such as malaria and dengue fever.

3 Jun 2021

Large-scale expansion of spike-reactive T cells feasible after COVID-19 vaccination

A new bioRxiv* preprint reports on the successful use of a protocol to expand SARS-CoV-2-reactive T-cells a thousand-fold.

2 Jun 2021

Study: Children who share their bed with pets get a good night's sleep

There is a long-held belief that having your pet sleep on the bed is a bad idea. Aside from taking up space, noisy scratching, or triggering allergies, the most common assertion averred that your furry companion would disrupt your sleep.

2 Jun 2021

NIH supports a new strategy to reduce side effects of head and neck cancer treatment

A new strategy to reduce the side effects suffered by patients undergoing treatment for head and neck cancers now has the support of the National Institutes of Health.

2 Jun 2021

NIH-supported study aims to improve gestational diabetes screening and diagnosis

A new study supported by the National Institutes of Health aims to improve gestational diabetes screening and diagnosis by better understanding blood glucose levels throughout pregnancy.

2 Jun 2021

From racial justice to dirty air, California’s new AG plots a progressive health care agenda

California Attorney General Rob Bonta, a longtime Democratic state lawmaker, comes to his new role well known for pursuing an unabashedly progressive agenda on criminal justice issues.

2 Jun 2021

Cmed Technology Adds More Capabilities to its Encapsia Platform and Reports Increased Demand for Use in Decentralized Trials (DCT)

Innovative technology for clinical trials is now, more than ever, necessary to deliver decentralized trials (DCT) and enable design of hybrid protocols that support trial continuity and patient-centricity.

2 Jun 2021

Could 3D printed swabs be used to collect COVID-19 test samples?

Researchers have evaluated 3D printed sample collection swabs made in-house and found them to be a reliable alternative to commercial swabs.

2 Jun 2021

Aptamer Group and PinotBio collaborate to develop new therapeutic drug conjugates

Aptamer Group Limited and PinotBio today announce that they have entered into a strategic collaboration agreement.

From Aptamer Group 2 Jun 2021

Technology News and Research

Oncologists underestimate patient use of complementary medicine after breast cancer diagnosis

Study: Some Type 2 diabetes patients can benefit from bone marrow stem cell transplants

How can nanomaterials help in the fight against COVID-19?

Researchers develop rapid antibody screening method for novel COVID-19 therapeutics development

Scientists assess the filtration efficacy of 227 models of face masks sold in Brazil

New nano-sized particles help improve detection of tumors within the body

Centivax and US Naval Medical Research Center to begin Phase I clinical trial of antibody therapeutics

E6-specific inhibitors offer a unique, strategic approach for treating HPV-HNSCC

Study could help scientists, policymakers communicate about zoonotic diseases

New process could reinvigorate the search for natural product drugs to treat cancers, viral infections

NCI grants more than $4.2 million to launch Cancer Epitope Database and Analysis Resource

Scientists develop new gene drive with a built-in genetic barrier

Large-scale expansion of spike-reactive T cells feasible after COVID-19 vaccination

Study: Children who share their bed with pets get a good night's sleep

NIH supports a new strategy to reduce side effects of head and neck cancer treatment

NIH-supported study aims to improve gestational diabetes screening and diagnosis

From racial justice to dirty air, California’s new AG plots a progressive health care agenda

Cmed Technology Adds More Capabilities to its Encapsia Platform and Reports Increased Demand for Use in Decentralized Trials (DCT)

Could 3D printed swabs be used to collect COVID-19 test samples?

Aptamer Group and PinotBio collaborate to develop new therapeutic drug conjugates

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News